Biomarin Pharmaceutical BMRN
NASDAQ BMRN
$57.18 -1.26 (-2.16%)
At close: Oct 2, 2026 · 4:00 PM EDT

Biomarin Pharmaceutical (BMRN) Gains from Sales and Divestitures (2014 - 2024)

Updated

Biomarin Pharmaceutical's Gains from Sales and Divestitures was $10 million in FY2024.

Analysis

Biomarin Pharmaceutical (BMRN) Gains from Sales and Divestitures (2014 - 2024) Analysis & Trends

From FY2014 onward, Biomarin Pharmaceutical has reported Gains from Sales and Divestitures for 8 years.

  • Gains from Sales and Divestitures shows a five-year compound annual growth rate of -16.7% (FY2019 to FY2024).
  • The FY2024 figure marks the lowest annual Gains from Sales and Divestitures in data going back to FY2014.
  • Per Business Quant data, Gains from Sales and Divestitures in earlier years was $108 million in FY2022 and $52.82 million in FY2020 (+111.3%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Biomarin Pharmaceutical 11.07 Bn 4.93 Bn 786.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 10.00 Mn
Mar 31, 2022 108.00 Mn
Dec 31, 2020 -6.68 Mn
Mar 31, 2020 59.50 Mn
Dec 31, 2019 10.00 Mn
Jun 30, 2019 15.00 Mn
Dec 31, 2018 30.00 Mn
Jun 30, 2018 20.00 Mn
Dec 31, 2017 125.00 Mn
Dec 31, 2015 369.50 Mn
Sep 30, 2014 67.50 Mn
API Access

Biomarin Pharmaceutical Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=BMRN&period=max&api_key=YOUR_API_KEY